Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey L Rogers

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|November 4, 2008
Multiple path analysis of reflectance from turbid mediaGeoffrey L Rogers
Frontiers in Bioscience (Landmark Edition)|January 2, 2015
Gene therapy for hemophiliaGeoffrey L Rogers, Roland W Herzog
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious DiseasesGeoffrey L Rogers, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2014
One microRNA controls both angiogenesis and TLR-mediated innate immunity to nucleic acidsGeoffrey L Rogers, Roland W Herzog
Clinical Immunology (Orlando, Fla.)|May 24, 2011
Protein transduction for tolerance inductionGeoffrey L Rogers, Roland W Herzog
Journal of Genetic Syndromes & Gene Therapy|December 25, 2012
Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia BGeoffrey L Rogers, Brad E Hoffman
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Genome edited B cells: a new frontier in immune cell therapiesGeoffrey L Rogers, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"Geoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2019
Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA BreakGeoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Journal of Translational Medicine|January 28, 2014
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BGeoffrey L Rogers, Ashley T Martino, Irene Zolotukhin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of the Optical Society of America. A, Optics, Image Science, and Vision|November 4, 2008
Multiple path analysis of reflectance from turbid mediaGeoffrey L Rogers
Frontiers in Bioscience (Landmark Edition)|January 2, 2015
Gene therapy for hemophiliaGeoffrey L Rogers, Roland W Herzog
Hematology/Oncology Clinics of North America|September 13, 2017
Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious DiseasesGeoffrey L Rogers, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2014
One microRNA controls both angiogenesis and TLR-mediated innate immunity to nucleic acidsGeoffrey L Rogers, Roland W Herzog
Clinical Immunology (Orlando, Fla.)|May 24, 2011
Protein transduction for tolerance inductionGeoffrey L Rogers, Roland W Herzog
Journal of Genetic Syndromes & Gene Therapy|December 25, 2012
Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia BGeoffrey L Rogers, Brad E Hoffman
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2021
Genome edited B cells: a new frontier in immune cell therapiesGeoffrey L Rogers, Paula M Cannon
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 19, 2019
Reply to "Efficient Nuclease-free HR by Clade F AAV Requires High MOIs with High Quality Vectors"Geoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2019
Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA BreakGeoffrey L Rogers, Hsu-Yu Chen, Heidy Morales, et al.
Journal of Translational Medicine|January 28, 2014
Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia BGeoffrey L Rogers, Ashley T Martino, Irene Zolotukhin, et al.
Pageof 3